Status:
COMPLETED
Heart Rate Changes Following the Administration of Sugammadex
Lead Sponsor:
Joseph D. Tobias
Conditions:
Bradycardia
Eligibility:
All Genders
Up to 18 years
Brief Summary
This a prospective study when the clinician decides to use sugammadex, heart rate will be recorded every minute for 15 minutes following its administration. If bradycardia occurs and a clinical decisi...
Eligibility Criteria
Inclusion
- Patient age 0-18 years
- Anesthetic plan includes NMB reversal with sugammadex
Exclusion
- Sugammadex not used during the case
Key Trial Info
Start Date :
September 6 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 10 2019
Estimated Enrollment :
276 Patients enrolled
Trial Details
Trial ID
NCT03294018
Start Date
September 6 2017
End Date
January 10 2019
Last Update
October 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nationwide Children's Hospital
Columbus, Ohio, United States, 43205